Molecular Techniques in Cancer Diagnosis and Management

摘要: The introduction of targeted therapeutics into clinical oncology practice has created opportunities for further development molecular diagnostics to serve cancer patients. approvals Herceptin™ the treatment HER-2/neu overexpressing breast and Gleevac™ chronic myelogenous leukemia featuring a bcr/abl translocation gastrointestinal stromal tumors with selective c-kit oncogene activating mutations have brought an expanded role diagnostic laboratory testing patients determine their eligibility receive these new therapies (1,2). industry is in state rapid evolution, technological development, novel applications (3-5). As seen Table 1, vitro now believed consist $33 billion market which currently less than 3%.